AU6771300A - Identication and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication - Google Patents

Identication and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication

Info

Publication number
AU6771300A
AU6771300A AU67713/00A AU6771300A AU6771300A AU 6771300 A AU6771300 A AU 6771300A AU 67713/00 A AU67713/00 A AU 67713/00A AU 6771300 A AU6771300 A AU 6771300A AU 6771300 A AU6771300 A AU 6771300A
Authority
AU
Australia
Prior art keywords
viral
identication
proteins
host cell
antiviral compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU67713/00A
Other languages
English (en)
Inventor
Ronald Harty
Robert O'neill
Peter M. Palese
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Icahn School of Medicine at Mount Sinai
Original Assignee
Mount Sinai School of Medicine
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mount Sinai School of Medicine filed Critical Mount Sinai School of Medicine
Publication of AU6771300A publication Critical patent/AU6771300A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1055—Protein x Protein interaction, e.g. two hybrid selection
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983—Viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/16011—Orthomyxoviridae
    • C12N2760/16111—Influenzavirus A, i.e. influenza A virus
    • C12N2760/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20211—Vesiculovirus, e.g. vesicular stomatitis Indiana virus
    • C12N2760/20222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
    • G01N2333/08—RNA viruses
    • G01N2333/11—Orthomyxoviridae, e.g. influenza virus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Plant Pathology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU67713/00A 1999-08-11 2000-08-11 Identication and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication Abandoned AU6771300A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US14826399P 1999-08-11 1999-08-11
US60/148263 1999-08-11
PCT/US2000/022257 WO2001011335A2 (fr) 1999-08-11 2000-08-11 Identification et utilisation de composes antiviraux inhibiteurs de l'interaction des proteines cellulaires et des proteines virales necessaires a la replication virale

Publications (1)

Publication Number Publication Date
AU6771300A true AU6771300A (en) 2001-03-05

Family

ID=22525014

Family Applications (1)

Application Number Title Priority Date Filing Date
AU67713/00A Abandoned AU6771300A (en) 1999-08-11 2000-08-11 Identication and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication

Country Status (2)

Country Link
AU (1) AU6771300A (fr)
WO (1) WO2001011335A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101471245B1 (ko) 2012-05-31 2014-12-10 충북대학교 산학협력단 Ａ형 인플루엔자 바이러스 감염 질환의 예방 및 치료용 조성물

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5750394A (en) * 1994-05-20 1998-05-12 The Mount Sinai Medical Center Identification and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication

Also Published As

Publication number Publication date
WO2001011335A3 (fr) 2005-03-10
WO2001011335A9 (fr) 2002-07-11
WO2001011335A2 (fr) 2001-02-15

Similar Documents

Publication Publication Date Title
AU4657500A (en) Locked nucleic acid hybrids and methods of use
EP1001813B8 (fr) Formulations pharmaceutiques contenant du voriconazole
AU1364799A (en) Use of aliphatic polyamines for reducing oxalate
AU4049589A (en) Rna and dna amplification techniques
AU6111000A (en) Inhibitors of viral helcase
AU6774294A (en) Methods of preventing viral replication
AU2415299A (en) Substituted benzenesulfonamide derivatives and their pharmaceutical use
AU5724000A (en) Anastomosis system and methods for use
AU7597998A (en) Herpes simplex virus vp22 vaccines and methods of use
AU1870497A (en) Buffer systems for use in stabilizing pharmaceutical preparations
AU4268796A (en) Acetamidine derivatives and their use as inhibitors for the nitric oxide synthase
AU4248297A (en) Inhibition of viral replication
EP1144397A3 (fr) Thio-urees a carboxamide heterocyclique inhibitrices des virus de l'herpes et contenant un groupe phenylenediamine
AU2001282986A1 (en) The protein kinase domain of the large subunit of herpes simplex type 2 ribonucleotide reductase (icp10pk) has anti-apoptopic activity
AU5791799A (en) Xanthine compound preparations and new uses thereof
AU5428700A (en) Acrylic acid derivatives, use of the same and intermediates for the preparation thereof
AU6771300A (en) Identication and use of antiviral compounds that inhibit interaction of host cell proteins and viral proteins required for viral replication
AU1451200A (en) Dual reporter system and methods of use therefor
AU6120298A (en) 2-peperazinone-1-acetic acid derivatives and their use
AU5569200A (en) Uracil compounds and use thereof
AU7173698A (en) Lipophilic and/or lytic peptides for specific delivery of nucleic acids to ce lls
EP0861322A4 (fr) Composes antiviraux inhibant l'interaction entre proteines de cellules hotes et proteines de virus necessaires a la replication
AU1894601A (en) Novel gene and use thereof
AU7119798A (en) Herpes simplex virus us3 and icp4 as inhibitors of apoptosis
AU6749900A (en) Dna replication proteins of gram positive bacteria and their use to screen for chemical inhibitors

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase